422
Participants
Start Date
May 15, 2024
Primary Completion Date
June 17, 2025
Study Completion Date
June 17, 2026
Sonelokimab
Sonelokimab
Placebo
Placebo
Clinical Site, Budapest
Clinical Site, Sofia
Clinical Site, Sofia
Clinical Site, Sofia
Clinical Site, Debrecen
Clinical Site, Debrecen
Clinical SIte, Pleven
Clinical Site, Pécs
Clinical Site, New York
Clinical Site, Torino
Clinical Site, The Bronx
Clinical Site, Berlin
Clinical Site, Mahlow
Clinical Site, Rozzano
Clinical Site, Milan
Clinical Site, Buxtehude
Clinical Site, Forest
Clinical Site, Brescia
Clinical Site, Oldenburg
Clinical Site, Charleston
Clinical Site, Hanover
Clinical Site, Sandy Springs
Clinical Site, Macon
Clinical Site, Margate
Clinical Site, Coral Springs
Clinical Site, Coral Gables
Clinical Site, Miami
Clinical Site, Hollywood
Clinical Site, Tampa
Clinical Site, Nashville
Clinical Site, Louisville
Clinical Site, Modena
Clinical Site, Wuppertal
Clinical Site, Mayfield Heights
Clinical Site, Cona
Clinical Site, Boardman
Clinical Site, Bochum
Clinical Site, Essen
Clinical Site, Dayton
Clinical Site, New Albany
Clinical Site, Columbus
Clinical Site, Warren
Clinical Site, Dearborn
Clinical Site, Münster
Clinical Site, Florence
Clinical Site, Pisa
Clinical Site, Torrette
Clinical Site, West Dundee
Clinical Site, Frankfurt
Clinical Site, Chieti
Clinical Site, Metairie
Clinical Site, Oklahoma City
Clinical Site, Frisco
Clinical Site, Houston
Clinical Site, Houston
Clinical Site, Napoli
Clinical Site, München
Clinical Site, South Jordan
Clinical Site, Las Vegas
Clinical Site, Langenau
Clinical Site, Los Angeles
Clinical Site, Erlangen
Clinical Site, Northridge
Clinical Site, San Diego
Clinical Site, Catania
Clinical Site, Sacramento
Clinical Site, Mill Creek
Clinical Site, Boston
Clinical Site, Boston
Clinical Site, Edmonton
Clinical Site, Edmonton
Clinical Site, Sherwood Park
Clinical Site, Winnipeg
Clinical Site, Fredericton
Clinical Site, Barrie
Clinical Site, London
Clinical Site, Markham
Clinical Site, Newmarket
Clinical Site, Toronto
Clinical Site, Toronto
Clinical Site, Montreal
Clinical Site, Québec
Clinical Site, Sherbrooke
Clinical SIte, Halle
Clinical Site, Perugia
Clinical Site, Rome
Clinical Site, Oslo
Clinical Site, Bialystok
Clinical Site, Gdansk
Clinical Site, Krakow
Clinical Site, Krakow
Clinical Site, Lodz
Clinical Site, Lodz
Clinical Site, Lublin
Clinical Site, Ossy
Clinical Site, Poznan
Clinical Site, Sosnowiec
Clinical Site, Szczecin
Clinical Site, Warsaw
Clinical Site, Warsaw
Clinical Site, Warsaw
Clinical Site, Wroclaw
Clinical Site, Lisbon
Clinical Site, Lisbon
Clinical Site, Porto
Clinical Site, Cardiff
Clinical Site, Dudley
Clinical Site, Leeds
Clinical Site, Salford
Lead Sponsor
MoonLake Immunotherapeutics AG
INDUSTRY